BB hero 5
Partner

Jens Chr. Hesse Rasmussen

Photo of Jens Chr. Hesse Rasmussen

Jens Christian Hesse Rasmussen specialises in M&A

Jens Chr. Hesse Rasmussen advises Danish and international clients on the acquisition and sale of enterprises, private equity and venture capital investments and the establishment of, reorganisation of, and investment in private equity funds.

He advises on regulatory issues, transactional structure and contractual documentation, such as transfer, investment and shareholders' agreements. Jens Chr. has extensive experience in structuring equity-based incentive schemes and the employment and taxation aspects of transactions. 

Jens Chr. represents clients in lawsuits and arbitration proceedings within his area of expertise and also acts as an arbitrator.

His expertise moreover extends to the AIFM Directive and the Danish regulation of alternative investment fund managers. 

Jens Chr. serves as a director in several small and medium-sized Danish companies.

The Team

M&A & Corporate Matters

  • M&A & Corporate Matters
  • Financing
  • Capital Markets
00 / 00

Engagements

  • Board member, Business Angels Fond - London III A/S
  • Board member, Brd. Klee A/S
  • Board member, AEG Electronfoundation, Research and Education Grant
  • Board of directors (chairman), Frontier Investment Management ApS
  • Board member, Combipack Danmark A/S
  • Board of directors (chairman), DI Frontier Market Energy & Carbon GP Holding ApS
  • The Association of Danish Law Firms, member of the international committee
  • Member, Danish Association of Company Law
  • Member, Forum for Company Law and Financial Market Law (FOCOFIMA)
  • Board of directors (member), A&D Resources A/S
  • Member, Danish Venture Capital and Private Equity Association (DVCA)

Publications

  • Deadlock-situationer i ejer- og joint venture-aftaler, DVCA - Danish Venture Capital and Private Equity Association, 2013. Article

Education and language

  • Right of audience, The Danish High Court
  • Admission to practice law
  • Master of Laws
  • English
  • Norwegian
  • Swedish

Ratings

It is on the M&A side that the firm perhaps shines the brightest, consistently coming out as one of the most active firms in the region for new deals. One example of that this year saw Jens Christian Hesse Rasmussen lead the way as the firm advised BioAlliance Pharma, a French-listed company, on its cross-border merger with the Danish –listed Topotarget. The firm’s client continued as the operating company so the deal involved the delisting of Topotarget and secondary listing of the new entity, Onxeo, on the Copenhagen exchange.

Elsewhere, Jacob Hjortshøj led a team advising Altor Fund III on the sale of the Sonion Group to Novo, a deal involving interests in seven different countries around the world: Denmark, Poland, the Netherlands, USA, China, Vietnam and the Philippines.

IFLR1000, Mergers and acquisitions